References
- Akash MSH, Rehman K, Chen S. (2013b). Role of inflammatory mechanisms in pathogenesis of type 2 diabetes mellitus. J Cell Biochem 114:525–31
- Akash MSH, Rehman K, Gillani Z, et al. (2013c). Cross-species comparison of IL-1Ra sequence between human and rat. J Proteomics Bioinform 6:038–42
- Akash MSH, Rehman K, Sun H, Chen S. (2013a). Interleukin-1 receptor antagonist improves normoglycemia and insulin sensitivity in diabetic Goto-Kakizaki-rats. Eur J Pharmacol 701:87–95
- Akash MSH, Shen Q, Rehman K, Chen S. (2012). Interleukin-1 receptor antagonist: A new therapy for type 2 diabetes mellitus. J Pharm Sci 101:1647–58
- Brown JM. (2000). Exploiting the hypoxic cancer cell: Mechanisms and therapeutic strategies. Mol Med Today 6:157–62
- Chen TZ. (2001). The exploitation of HAS and its application in tumor therapy. Prog Microbiol Immunol 29:63–9
- Chen, TZ. (2005). Gaojushen: A novel anti-cancer drug prepared from SEC superantigen. Prog Microbiol Immunol 33:49–50
- Ding D, Huang P, Pan Y, Chen S. (2011). Gene detection of staphylococcal enterotoxins in production strain of staphylococcin injection and superantigenic activity of rSEK and rSEQ. World J Microbiol Biotechnol 27:2957–67
- Ding D, Huang P, Sun HY, et al. (2009). Identification of protein components and quantitative immunoassay for SEC2 in staphylococcin injection. J Pharmaceut Biomed Anal 50:79–85
- Dinges MM, Orwin PM, Schlievert PM. (2000). Exotoxins of Staphylococcus aureus. Clin Microbiol 13:16–34
- Hansson J, Ohlsson L, Persson R, et al. (1997). Genetically engineered superantigens as tolerable antitumor agents. Proc Natl Acad Sci USA 94:2489–94
- Hosoya K, Takashima T, Matsuda K, Terasaki T. (2002). Spleen lymphocyte kinetics in mice under normal and inflammatory conditions: An application of the transgenic mouse expressing beta-galactosidase (ROSA 26). Biol Pharm Bull 25:1378–80
- Jie KG, Jiang H, Sun L, et al. (2007). The pilot study of anti-tumor effects versus immunosuppression of Staphylococcal enterotoxin C. Cancer Biol Ther 6:1584–91
- Lane DP, Brown CJ, Verma C, Cheok CF. (2011). New insights into p53 based therapy. Discov Med 12:107–17
- Luo J, Solimini NL, Elledge SJ. (2009). Principles of cancer therapy: Oncogene and non-oncogene addiction. Cell 136:823–37
- Luo P, Lv HX, Zang SM. (2007). Preparation and preliminary application of monoclonal antibody against Staphylococcal enterotoxin C2. Zhongguo Mianyixue Zazhi 23:53–5
- Morandi S, Brasca M, Lodi R, et al. (2007). Detection of classical enterotoxins and identification of entero toxin genes in Staphylococcus aureus from milk and dairy products. Vet Microbiol 124:66–72
- Pan YQ, Ding D, Li DX, Chen SQ. (2007). Expression and bioactivity analysis of Staphylococcal enterotoxin M and N. Protein Expr Purif 56:286–92
- Parveen A, Akash MSH, Rehman K, et al. (2012). Biodisposition kinetics of isoniazid in healthy females. J App Pharm 4:676–81
- Patyar S, Joshi R, Byrav DS, et al. (2010). Bacteria in cancer therapy: A novel experimental strategy. J Biomed Sci 17:21
- Rehman K, Akash MSH, Azhar S, et al. (2012). A biochemical and histopathologic study showing protection and treatment of gentamicin-induced nephrotoxicity in rabbits using vitamin C. Afr J Tradit Complement Altern Med 9:360–5
- Saleem U, Ahmed B, Rehman K, et al. (2012). Nephro-protective effect of vitamin C and Nigella sativa oil on gentamicin associated nephrotoxicity in rabbits. Pak J Pharm Sci 25:727–30
- Shaheen M, Allen C, Nickoloff JA, Hromas R. (2011). Synthetic lethality: Exploiting the addiction of cancer to DNA repair. Blood 117:6074–82
- Stiles BG, Bavari S, Krakauer T, Ulrich RG. (1993). Toxicity of Staphylococcal enterotoxins potentiated by lipopolysaccharide: Major histocompatibility complex class II molecule dependency and cytokine release. Infect Immun 61:5333–8
- Ulrich RG. (2006). Evolving superantigens of Staphylococcus aureus. FEMS Immunol Med Microbiol 27:1–7
- Van Belkum A, Melles DC, Snijders SV, et al. (2006). Clonal distribution and differential occurrence of the enterotoxin gene cluster, egc, in carriage- versus bacteremia-associated isolates of Staphylococcus aureus. J Clin Microbiol 44:1555–7
- Xue Q, Ying YB, Pan YQ, et al. (2006). Expression and bioactivity analysis of Staphylococcal enterotoxin C2. Yao Xue Xue Bao 41:406–11